Quick Answer
Tonix Pharmaceuticals Holding Corp. reported Cash And Cash Equivalents At Carrying Value of $207.64 million for the year ending 2025.
- Tonix Pharmaceuticals Holding Corp. showed an increase of +110.2% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Tonix Pharmaceuticals Holding Corp.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), Tonix Pharmaceuticals Holding Corp.'s Cash And Cash Equivalents At Carrying Value has grown by 11,532.3%.
- Historical annual values: Fiscal year 2025: $207.64 million | Fiscal year 2024: $98.78 million | Fiscal year 2023: $24.95 million | Fiscal year 2022: $120.23 million | Fiscal year 2021: $178.66 million | Fiscal year 2020: $77.07 million | Fiscal year 2019: $11.25 million | Fiscal year 2018: $25.03 million | Fiscal year 2017: $25.50 million | Fiscal year 2016: $18.94 million | Fiscal year 2015: $19.18 million | Fiscal year 2014: $38.18 million | Fiscal year 2013: $8.20 million | Fiscal year 2012: $1.79 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: